Overview

GTA-Glyceryltriacetate for Canavan Disease

Status:
Unknown status
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether oral supplementation of glyceryl triacetate improves the clinical prognosis of Canavan Disease.
Phase:
Phase 1
Details
Lead Sponsor:
Sheba Medical Center